Ftse Mib
35.398,82
-0,03%
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
NASDAQ
16.685,97
-0,07%
Bitcoin
66.980,17
0,06%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sio Gene Therapies Inc (SIOX) Sio Gene Therapies Inc (SIOX) Notizie

SIOX

Sio Gene Therapies (SIOX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SIOX
DataOraFonteTitoloSimboloCompagnia
02/02/202413:00GlobeNewswire Inc.Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per ShareNASDAQ:SIOXSio Gene Therapies Inc
25/04/202322:05Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:SIOXSio Gene Therapies Inc
17/04/202322:17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:SIOXSio Gene Therapies Inc
17/04/202322:14Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:SIOXSio Gene Therapies Inc
12/04/202314:52Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:SIOXSio Gene Therapies Inc
06/04/202322:08Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:SIOXSio Gene Therapies Inc
06/04/202322:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SIOXSio Gene Therapies Inc
17/03/202311:03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:SIOXSio Gene Therapies Inc
21/02/202322:06Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:SIOXSio Gene Therapies Inc
14/02/202313:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Third Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
14/02/202312:47Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SIOXSio Gene Therapies Inc
13/02/202314:53Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:SIOXSio Gene Therapies Inc
10/02/202322:01Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:SIOXSio Gene Therapies Inc
09/02/202312:01Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (preliminary) (prem14a)NASDAQ:SIOXSio Gene Therapies Inc
14/12/202222:49GlobeNewswire Inc.Sio Gene Therapies Inc. Announces Board Approval of Plan of Complete Liquidation and DissolutionNASDAQ:SIOXSio Gene Therapies Inc
10/11/202213:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Second Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
11/08/202213:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal First Quarter 2022 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
14/06/202213:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SIOXSio Gene Therapies Inc
14/06/202213:00GlobeNewswire Inc.Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
28/04/202215:05TipRanksAnalyst Explains Why They Downgraded Their Rating on Sio Gene Therapies (SIOX)NASDAQ:SIOXSio Gene Therapies Inc
27/04/202222:25GlobeNewswire Inc.Sio Gene Therapies Provides Corporate UpdateNASDAQ:SIOXSio Gene Therapies Inc
11/02/202213:00GlobeNewswire Inc.Sio Gene Therapies Announces Corporate Updates and Fiscal Third Quarter 2021 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
10/02/202223:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:SIOXSio Gene Therapies Inc
02/02/202213:00GlobeNewswire Inc.Sio Gene Therapies to Present at the 18th Annual WORLDSymposium™ 2022NASDAQ:SIOXSio Gene Therapies Inc
31/01/202222:01GlobeNewswire Inc.Sio Gene Therapies Announces Prioritization of Lead Gene Therapy Programs in GM1 and GM2 Gangliosidosis, Extension of Cash Runway, and CEO TransitionNASDAQ:SIOXSio Gene Therapies Inc
12/11/202113:00GlobeNewswire Inc.Sio Gene Therapies Announces Corporate Updates and Fiscal Second Quarter 2021 Financial ResultsNASDAQ:SIOXSio Gene Therapies Inc
11/11/202113:00GlobeNewswire Inc.Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s DiseaseNASDAQ:SIOXSio Gene Therapies Inc
01/11/202112:00GlobeNewswire Inc.Sio Gene Therapies Announces Granting of FDA Fast Track Designation for Investigational AXO-AAV-GM2 Gene Therapy in Patients with GM2 GangliosidosisNASDAQ:SIOXSio Gene Therapies Inc
21/10/202123:00GlobeNewswire Inc.Sio Gene Therapies Announces Reorganization of R&D GroupNASDAQ:SIOXSio Gene Therapies Inc
21/10/202114:56Dow Jones NewsSio Gene Therapies Gets FDA Fast-Track Designation for AXO-AAV-GM1 in GM1 GangliosidosisNASDAQ:SIOXSio Gene Therapies Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SIOX

La tua Cronologia

LSE
XREP
Ivz Us Real Est
EU
ESGBP
BEL ESG
NASDAQ
NDSN
Nordson
BIT
UB8VR0
Unicredit Bank
USOTC
ADCUF
ADS Maritime (GM)
BOV
D2KN34M
DraftKings
BIT
Q00258
Leonteq Securities
AQSE
GBDV.GB
State Street Global Advi...
COIN
FOXETH
FOX (ShapeShift)
AMEX
SKJ
USOTC
LLGCF
Lendlease Global Commerc... (PK)
TSXV
CAN
NASDAQ
PPDI
Pharmaceutical Product Developme
BOV
BUFF39
Xtrackers Msci World Val...
DBI
DTFM
IDDAX 6X LEVER NC TR EO
COIN
UPPEUR
Sentinel Protocol
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network